A fluorometric assay for L-asparaginase activity and monitoring of L-asparaginase therapy.
The antineoplastic enzyme L-asparaginase is commonly used for the induction of remission in acute lymphoblastic leukemia (ALL). There is no simple method available for measuring the activity of this highly toxic drug. We incubated L-asparaginase from Erwinia chrysanthemi with L-aspartic acid beta-(7-amido-4-methylcoumarin) and measured the release of 7-amino-4-methylcoumarin fluorometrically for 30-300 min. The rate of the hydrolysis of the substrate was linear over a 50-fold range of the concentration of the enzyme. With increasing substrate concentration, the enzyme showed a saturable kinetic pattern with V(max) of 0.547 (SD 0.059) microM/min/mg of enzyme (n = 3) and Km of 0.302 (SD 0.095) mM (n = 3). This assay enables rapid analysis of L-asparaginase activity in biological samples and it can be used, for example, for monitoring of L-asparaginase activity in serum of ALL patients during their L-asparaginase therapy.
Ylikangas
P
P
Department of Clinical Chemistry, Päijät-Häme Central Hospital, Lahti, Finland.
Mononen
I
I
D000293:Adolescent; D000970:Antineoplastic Agents / Q000097:blood / Q000627:therapeutic use*; D001215:Asparaginase / Q000097:blood / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D016903:Drug Monitoring / Q000379:methods*; D006801:Humans; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000097:blood / Q000188:drug therapy*; D012680:Sensitivity and Specificity; D013050:Spectrometry, Fluorescence
D000970:Antineoplastic Agents; D001215:Asparaginase